PARP1 inhibitor (PJ34) improves the function of aging-induced endothelial progenitor cells by preserving intracellular NAD+ levels and increasing SIRT1 activitySiyuan Zha, Fang Liu|Stem Cell Research & Therapy|2018Cited by 50